176 episodes

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

PeerVoice Internal Medicine Audio PeerVoice

    • Science
    • 4.8 • 4 Ratings

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

    Carlo Antozzi, MD - From Helsinki: Expert Perspectives on the Next Generation of Clinical Evidence for FcRn Inhibitors in Myasthenia Gravis

    Carlo Antozzi, MD - From Helsinki: Expert Perspectives on the Next Generation of Clinical Evidence for FcRn Inhibitors in Myasthenia Gravis

    Visit https://www.peervoice.com/JAQ860 to view the entire programme with slides. After completing “Carlo Antozzi, MD - From Helsinki: Expert Perspectives on the Next Generation of Clinical Evidence for FcRn Inhibitors in Myasthenia Gravis”, participants will be able to: Summarise the latest clinical data on emerging FcRn inhibitors in generalised myasthenia gravis (gMG); and Evaluate how emerging evidence is advancing identification of the need for, and optimised management with, FcRn inhibitors in patients with gMG.

    • 20 min
    Xenofon Baraliakos, MD, PhD / Philip Helliwell, MD, PhD - Can the Standard of Care Be Elevated in Spondyloarthropathies? Key Learnings From Rheumacensus Initiatives in PsA and axSpA

    Xenofon Baraliakos, MD, PhD / Philip Helliwell, MD, PhD - Can the Standard of Care Be Elevated in Spondyloarthropathies? Key Learnings From Rheumacensus Initiatives in PsA and axSpA

    Visit https://www.peervoice.com/AFQ860 to view the entire programme with slides. After completing “Xenofon Baraliakos, MD, PhD / Philip Helliwell, MD, PhD - Can the Standard of Care Be Elevated in Spondyloarthropathies? Key Learnings From Rheumacensus Initiatives in PsA and axSpA”, participants will be able to: Describe the rationale, design, and key areas of focus of the Rheumacensus programmes in psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA); Identify the overarching calls to action needed to implement a paradigm shift designed to elevate health outcomes in patients with PsA and axSpA, as defined by the Rheumacensus Consensus Council; and Propose practical steps to elevate the standard of care for patients with PsA and axSpA based upon results of the Rheumacensus Initiatives.

    • 15 min
    Michael Thorpy, MD - When Sleep Is Exhausting: Improving Diagnosis and Outcomes in Patients With Idiopathic Hypersomnia

    Michael Thorpy, MD - When Sleep Is Exhausting: Improving Diagnosis and Outcomes in Patients With Idiopathic Hypersomnia

    Visit https://www.peervoice.com/DRF860 to view the entire programme with slides. After completing “Michael Thorpy, MD - When Sleep Is Exhausting: Improving Diagnosis and Outcomes in Patients With Idiopathic Hypersomnia”, participants will be able to: Recognize health risks associated with idiopathic hypersomnia; Differentiate idiopathic hypersomnia from other conditions that cause excessive daytime sleepiness (EDS); Explain how to establish a confirmatory diagnosis of idiopathic hypersomnia; and Propose effective, individualized, evidence-based management strategies for patients with idiopathic hypersomnia.

    • 1 hr 28 min
    Phyllis C. Zee, MD, PhD - Sleep, Heart, Brain: What Promotes and How to Reduce Cardiovascular Risk in Patients With Narcolepsy

    Phyllis C. Zee, MD, PhD - Sleep, Heart, Brain: What Promotes and How to Reduce Cardiovascular Risk in Patients With Narcolepsy

    Visit https://www.peervoice.com/RHA860 to view the entire programme with slides. After completing “Phyllis C. Zee, MD, PhD - Sleep, Heart, Brain: What Promotes and How to Reduce Cardiovascular Risk in Patients With Narcolepsy”, participants will be able to: Describe the pathophysiology of narcolepsy in the context of cardiovascular (CV) effects; Differentiate between narcolepsy medications regarding their impact on CV risk factors; Identify medications used for common comorbidities associated with narcolepsy that have the potential to increase CV risk; and Propose strategies to manage CV risk in patients with narcolepsy.

    • 1 hr 1 min
    Milan J. Anadkat, MD - Supporting Patient-Centered Care in Generalized Pustular Psoriasis: Communications Strategies to Improve Shared Decision-Making

    Milan J. Anadkat, MD - Supporting Patient-Centered Care in Generalized Pustular Psoriasis: Communications Strategies to Improve Shared Decision-Making

    Visit https://www.peervoice.com/HUM860 to view the entire programme with slides. After completing “Milan J. Anadkat, MD - Supporting Patient-Centered Care in Generalized Pustular Psoriasis: Communications Strategies to Improve Shared Decision-Making”, participants will be able to: Describe key information regarding the disease process and course following the diagnosis of generalized pustular psoriasis (GPP); Address common concerns raised by patients with GPP; and Develop appropriate treatment plans with patients for the management of GPP.

    • 33 min
    Angela Kay Fitch, MD, FACP, MFOMA - Unpacking Impressions and Perceptions of Novel Treatments for Obesity: How Would You Respond to These Questions in Primary Care?

    Angela Kay Fitch, MD, FACP, MFOMA - Unpacking Impressions and Perceptions of Novel Treatments for Obesity: How Would You Respond to These Questions in Primary Care?

    Visit https://www.peervoice.com/MAZ860 to view the entire programme with slides. After completing “Angela Kay Fitch, MD, FACP, MFOMA - Unpacking Impressions and Perceptions of Novel Treatments for Obesity: How Would You Respond to These Questions in Primary Care?”, participants will be able to: Explain the impact of weight reduction on patient health and the rationale for managing obesity as a chronic, treatable disease; Describe the mechanisms, evidence base, and role of novel anti-obesity medications, including incretin-based therapies; and Construct evidence-based responses to common practical questions related to the use of anti-obesity medications, including incretin-based therapies.

    • 49 min

Customer Reviews

4.8 out of 5
4 Ratings

4 Ratings

Top Podcasts In Science

Hidden Brain
Hidden Brain, Shankar Vedantam
Radiolab
WNYC Studios
Short Wave
NPR
Making Sense with Sam Harris
Sam Harris
Ologies with Alie Ward
Alie Ward
StarTalk Radio
Neil deGrasse Tyson

You Might Also Like

More by PeerVoice

PeerVoice Oncology & Haematology Audio
PeerVoice
PeerVoice Endocrinology & Metabolic Disorders Audio
PeerVoice
PeerVoice Heart & Lung Video
PeerVoice
PeerVoice Immunology & Infectious Disease Video
PeerVoice
PeerVoice Internal Medicine Video
PeerVoice
PeerVoice Immunology & Infectious Disease Audio
PeerVoice